This page shows the latest Myovant Sciences news and features for those working in and with pharma, biotech and healthcare.
The US Food and Drug Administration (FDA) has approved Myovant’s once-daily pill Orgovyx for prostate cancer. ... day,” said Lynn Seely, chief executive officer of Myovant Sciences.
Myovant Sciences will focus on delivering innovative therapies in the two areas, with former Medivation chief medical officer Lynn Seely appointed to lead the business. ... For its tie-up with Takeda, the Japanese firm has granted Myovant Sciences an
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Hello we’re Triducive. We’re a healthcare strategy and value consultancy that provides expert and insight-driven solutions that strengthen and realise...